Search Results - "Hannah M. Cranford"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    The prognostic role of cigarette smoking in Kidney Cancer Survival by Baral, Amrit, Cranford, Hannah M., Sharma, Janaki, Pinheiro, Paulo S.

    Published in Cancer medicine (Malden, MA) (01-07-2023)
    “…Background The role of cigarette smoking as a prognostic factor for kidney cancer (KC) is unclear. In this population‐based study, we analyze cancer‐specific…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Incidence of Etiology-specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity by Pinheiro, Paulo S., Jones, Patricia D., Medina, Heidy, Cranford, Hannah M., Koru-Sengul, Tulay, Bungum, Tim, Wong, Robert, Kobetz, Erin N., McGlynn, Katherine A.

    Published in Clinical gastroenterology and hepatology (01-03-2024)
    “…The main causes of hepatocellular carcinoma (HCC) include chronic hepatitis C and B viral infections (HCV, HBV), nonalcoholic fatty liver disease (NAFLD), and…”
    Get full text
    Journal Article
  8. 8

    Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis by Cranford, Hannah M, Jones, Patricia D, Wong, Robert J, Liu, Qinran, Kobetz, Erin N, Reis, Isildinha M, Koru-Sengul, Tulay, Pinheiro, Paulo S

    “…Previous survival studies on hepatocellular carcinoma (HCC) by etiology are limited to hospital-based series, restricted cohorts, and monolithic etiological…”
    Get full text
    Journal Article
  9. 9

    Population-based denominators matter: Bias in U.S. Virgin Islands COVID-19 vaccination coverage under changing population counts by Labgold, Katie, Cranford, Hannah M., Ekpo, Lisa L., Mac, Valerie V., Roth, Joseph, Stout, Monife, Ellis, Esther M.

    Published in Annals of epidemiology (01-07-2024)
    “…The U.S. Virgin Islands (USVI) receives an updated population count once every 10 years and used 2010 decennial census population counts to estimate COVID-19…”
    Get full text
    Journal Article
  10. 10

    Lung Cancer Incidence by Detailed Race-Ethnicity by Cranford, Hannah M, Koru-Sengul, Tulay, Lopes, Gilberto, Pinheiro, Paulo S

    Published in Cancers (05-04-2023)
    “…Lung cancer (LC) incidence rates and tumor characteristics among (non-Hispanic) Black and Hispanic detailed groups, normally characterized in aggregate, have…”
    Get full text
    Journal Article
  11. 11

    Abstract 1902: Lung cancer incidence by detailed race-ethnicity by Cranford, Hannah M.

    Published in Cancer research (Chicago, Ill.) (29-05-2023)
    “…Abstract Despite recent incidence and mortality declines, lung cancer (LC) is still the second most common and deadliest cancer in the US. Yet, LC incidence…”
    Get full text
    Journal Article
  12. 12

    Epidemiology of cholangiocarcinoma in Florida, and differences in risk factors between intra- and extra-hepatic cholangiocarcinoma by Pinheiro, Paulo S., Cranford, Hannah M., Liu, Qinran, Jones, Patricia Denise

    Published in Journal of clinical oncology (01-06-2023)
    “…e16329 Background: Albeit rare, cholangiocarcinoma (CC) is a poorly understood, highly fatal cancer with an incidence rate of less than 2.5 per 100,000 people…”
    Get full text
    Journal Article
  13. 13

    Hepatocellular carcinoma etiology drives survival outcomes: A population-based analysis by Cranford, Hannah M., Jones, Patricia Denise, Liu, Qinran, Koru-Sengul, Tulay, Reis, Isildinha M., Pinheiro, Paulo S.

    Published in Journal of clinical oncology (01-06-2024)
    “…e16142 Background: Previous studies on survival differences according to etiology of hepatocellular carcinoma (HCC) (5-year observed survival of 23%) are…”
    Get full text
    Journal Article
  14. 14

    Disparities in the prevalence of EGFR mutations and ALK rearrangements by racial-ethnic group in South Florida with a focus on Hispanic patients, 2011-2019 by Pinheiro, Paulo S., Liu, Qinran, Medina, Heidy, Cranford, Hannah M., Herna, Stuart Joseph, Rodriguez, Estelamari, Lopes, Gilberto

    Published in Journal of clinical oncology (01-06-2024)
    “…e20528 Background: We examined the prevalence and survival outcomes of EGFR+, ALK+, and receipt of Tyrosine Kinase Inhibitors (TKIs), among all 1,654 patients…”
    Get full text
    Journal Article
  15. 15
  16. 16